Necrotizing fasciitis/myositis in Adults - Culture proven
- Use of IV immune globulin (1-2g/kg/day x 2 days) could be considered if streptococcal toxic shock also present.
S. pyogenes (Group A Strep)
- Invasive Group A Streptococci is reportable to Public Health.
- Prophylaxis of contacts of invasive Group A Streptococci is recommended by most Public Health experts. See Prophylaxis for Contacts of Communicable Diseases.
Therapy |
Dose |
Duration |
Penicillin |
4MU IV q4h |
10-14 days |
+ |
|
|
Clindamycin |
600-900mg IV q8h |
Continue until hemodynamically stable and initial debridement complete (1-3 days) |
S. agalactiae (Group B Strep)
Group C, G Strep
S. pneumoniae
Pen MIC ≤ 0.12µg/mL
Therapy |
Dose |
Duration |
Penicillin |
4MU IV q4h |
10-14 days |
+ |
|
|
Clindamycin |
600-900mg IV q8h |
Continue until hemodynamically stable and initial debridement complete (1-3 days) |
Pen MIC > 0.12µg/mL
Therapy |
Dose |
Duration |
Ceftriaxone |
2g IV daily |
10-14 days |
+ |
|
|
Clindamycin |
600-900mg IV q8h |
Continue until hemodynamically stable and initial debridement complete (1-3 days) |
Methicillin-susceptible S. aureus (MSSA)
Therapy |
Dose |
Duration |
Cloxacillin |
2g IV q4h |
10-14 days |
+ |
|
|
Clindamycin |
600mg IV q8h |
Continue until hemodynamically stable and initial debridement complete (1-3 days) |
MRSA
Alternative